Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
4 drugs for “Non-Squamous Non-Small Cell Lung Cancer”
Approved 1
- CosibelimabCheckpoint Therapeutics, Inc.Metastatic Non-squamous Non Small Cell Lung Cancer
Phase 3 3
- Aglatimagene besadenovecCandel Therapeutics, Inc.Non-squamous, Non-Small Cell Lung Cancer
- AK112Summit Therapeutics Inc.Non-Squamous Non-small Cell Lung Cancer
- Telisotuzumab adizutecanAbbVie Inc.Non-Squamous Non-Small Cell Lung Cancer
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.